The Paris techbio company screens microbial genomes to find molecules that evolution spent three billion years producing, and claims to have characterised more novel small molecules in 2025 than the rest of the field combined. Alven and Daphni co-led the Series A. Generare, the Paris-based techbio company reading microbial genomes for molecules that drug development […]
This story continues at The Next Web